Toradol 10 mg Tablets

Toradol is the brand of oral ketorolac tablets we offer for the short-term continuation of treatment for moderately severe acute pain. Every option contains the same active ingredient, 10 mg strength and oral tablet form; the only catalogue choice is package quantity. We offer six quantities ranging from 60 to 360 tablets. Because ketorolac has strict dose and duration limits, the packages we offer should be compared on price and unit value without treating a larger quantity as permission for longer or repeated use.

Our package and price comparison

The comparison below shows the package quantities and current prices available from us, together with the resulting price per tablet and relative package value. It is the appropriate place to compare exact figures without confusing a commercial package size with a medically suitable course.

A larger package may have a different unit price, but that does not make it the right option for an individual. Toradol tablets are not intended for routine, long-term or intermittent self-treatment. Before ordering, consider the authorised treatment duration, the quantity directed by the prescriber and whether the package would leave a substantial number of tablets unused.

What quantity is medically appropriate?

Oral ketorolac is generally used only as continuation treatment after ketorolac has first been given by injection. The maximum combined duration of injectable and oral ketorolac is five days, not five days for each form. The usual labelled adult ceiling is 40 mg per day, equivalent to four 10 mg tablets, and lower limits apply to some people, including adults over 65 years of age, people weighing under 50 kg and those with reduced kidney function.

Even the mathematical ceiling of 40 mg daily for five full days would equal 20 tablets. An oral continuation course would generally involve fewer because time spent receiving injectable ketorolac counts towards the same five-day limit. The smallest package we offer contains 60 tablets, so none of our package sizes represents a recommended single-course quantity. This distinction is important when interpreting the package comparison.

• Follow the dose and stop date specified by the prescriber rather than the number of tablets in the package.
• Do not extend a course to use remaining tablets or because symptoms continue.
• Do not reserve leftovers for a later episode of pain unless a prescriber has reassessed the situation and specifically directed another course.
• Ask a pharmacist how to dispose of unwanted or expired tablets safely rather than placing them in household wastewater.

A new or recurring pain episode may have a different cause or require a different treatment. A previous direction to use ketorolac does not establish that it is appropriate to restart it later.

One strength and oral tablet form

All Toradol options in our catalogue are 10 mg oral tablets. We do not offer another strength, an injectable presentation or a modified-release version under this listing. Package size therefore changes the number of tablets supplied and the total price, but it does not change the strength, route or clinical role of the medicine.

This consistency makes price comparison straightforward, but it also means customers should not use package quantity to adjust a dose. The prescribed number of 10 mg tablets and the interval between doses must remain within the individual directions provided by the prescriber.

Brand and alternative context

Toradol is a brand name for ketorolac. We do not list a separate generic ketorolac tablet, so there is no brand-versus-generic price choice for this active ingredient in our current catalogue. The available decision is between the package quantities shown in our comparison.

Ketorolac belongs to the non-steroidal anti-inflammatory drug class, commonly abbreviated to NSAID. Other pain medicines include ibuprofen, naproxen, Diclofenac, celecoxib, paracetamol and tramadol, while Voltaren is a brand associated with diclofenac. These medicines are not direct substitutes simply because they may be used for pain. They differ in indications, duration limits, interactions and risks, and some belong to a different medicine class altogether.

Anyone considering an alternative should discuss the type and duration of pain, other health conditions and current medicines with a prescriber or pharmacist. Combining ketorolac with another NSAID is particularly important to avoid.

Toradol's established short-term role

Ketorolac is used for moderately severe acute pain that requires treatment at an opioid level, commonly in a clinical or postoperative context. Oral tablets serve as short-term continuation rather than as the starting treatment. Toradol is not intended for minor pain, chronic pain or ongoing conditions such as long-term arthritis pain.

This narrow role explains why price per tablet cannot be the main clinical consideration. The safety risks increase with dose and duration, while the treatment limit remains short even if symptoms have not fully resolved. Persistent or worsening pain requires clinical review rather than an extended ketorolac course.

How does ketorolac work and how is it used?

Ketorolac reduces the activity of cyclo-oxygenase enzymes involved in producing prostaglandins. Prostaglandins contribute to pain and inflammation but also help protect the stomach lining, support kidney blood flow and assist normal platelet function. Reducing them can relieve acute pain while also accounting for important gastrointestinal, kidney and bleeding risks.

Toradol tablets are taken by mouth according to the prescriber's directions. Taking a dose with food may reduce minor stomach upset, but it does not prevent ulcers or gastrointestinal bleeding. The tablets should not be combined with aspirin used for pain relief or with another NSAID, including ibuprofen, naproxen or diclofenac, unless a prescriber has explicitly reviewed the combination.

Do not take an extra dose to compensate for a missed one. If the directions are unclear, confirm them with a pharmacist or prescriber rather than estimating from the number of tablets supplied. The total combined ketorolac treatment period must remain within five days.

Major safety considerations and interactions

Ketorolac can cause serious gastrointestinal bleeding, ulceration or perforation, sometimes without warning symptoms. It can also reduce kidney function, promote fluid retention and interfere with platelet function. Risk can be greater in older adults, people with kidney disease or dehydration, those with a history of ulcers or bleeding and people taking medicines that affect bleeding or kidney function.

Toradol is not suitable during pregnancy or breastfeeding. Oral ketorolac is not indicated for paediatric use, and its safety and effectiveness have not been established for children. It must also be avoided by anyone with previous hypersensitivity to ketorolac, aspirin or another NSAID, including aspirin- or NSAID-associated asthma, nasal polyps, hives or angioedema.

• Do not use it with another NSAID or pain-relief doses of aspirin.
• Check before use if taking anticoagulants, antiplatelet medicines, corticosteroids or certain antidepressants because bleeding risk may rise.
• Discuss diuretics and medicines for high blood pressure, as combinations can affect kidney function or reduce the response to treatment.
• Check lithium and methotrexate specifically because ketorolac can alter their handling by the body and increase toxicity risk.
• Tell the prescriber about kidney disease, dehydration, heart disease, high blood pressure, ulcers, gastrointestinal bleeding and previous NSAID reactions.

Urgent medical assessment is warranted for vomiting blood, black or bloody stools, severe abdominal pain, chest pain, breathing difficulty, facial swelling, a marked reduction in urine or a severe skin reaction. Ketorolac may also cause dizziness, drowsiness, vertigo or visual disturbance. Do not drive or operate machinery if affected.

Store the tablets at 20°C to 25°C, with permitted excursions between 15°C and 30°C. Protect them from light, keep the container tightly closed and keep all medicines out of reach of children. Always follow the storage instructions printed on the supplied packaging if they are more specific.

Australian status and our ordering policy

Systemic ketorolac is a Schedule 4 Prescription Only Medicine in Australia. That classification describes its status under Australian medicines regulation and is separate from our process for accepting an order. Ketorolac tablets are not listed as a Pharmaceutical Benefits Scheme medicine.

Under our current ordering policy for this Toradol listing, we do not require customers to submit a prescription document for us to accept an order. Our policy does not change the medicine's Schedule 4 classification, remove the need for appropriate medical direction or make a longer course suitable. The strict dose and five-day combined-duration limits continue to apply.

Suspected adverse events involving ketorolac can be reported to the Therapeutic Goods Administration. A prescriber or pharmacist can also advise how to obtain urgent care or report a suspected reaction.

Ordering and support from us

Once the appropriate quantity has been considered separately from the medicine's course limit, select one of the package options shown in our comparison. Our checkout collects the delivery and payment details needed to process the order. We then prepare, pack and dispatch accepted orders according to the information presented during checkout.

1. Review the strength and package quantity before adding Toradol to your cart.
2. Complete our checkout with accurate payment and delivery details.
3. Read the order confirmation and any delivery information we provide.
4. Contact us promptly if the order details need clarification.

Our support team is available 24/7 by email, online chat and phone. A pharmacist is also available for general medicine questions, including interactions, storage and the distinction between package size and treatment quantity. Our support does not replace assessment by the prescriber responsible for deciding whether ketorolac is appropriate or how much should be taken.

A value decision within strict treatment limits

Our package comparison makes the financial differences between the six options visible, but the lowest unit price is not automatically the best decision. Every package we offer contains more tablets than the maximum possible number for one five-day treatment period at the labelled adult ceiling, and many people require a lower dose or shorter oral continuation period.

Compare our prices only after separating package value from clinical need. Use no more than the amount specifically directed, do not prolong or restart treatment to consume leftovers and seek medical advice if pain continues. This approach keeps the price decision grounded in the medicine's unusually strict safety limits.